Antiviral supplement formulations
The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
1. An antiviral composition consisting of active ingredients including a therapeutically effective amount of from about 40% to about 80% by weight of a lysine, from about 15% to about 35% by combined weight of one or more ascorbic compounds, one or more flavonoid glycosides, a threonine, a taurine, a pyridoxine, and a pharmaceutically acceptable carrier.
2. The composition of claim 1 , wherein the lysine is from about 50% to about 70% by weight compared to the total weight of the active ingredients.
3. The composition of claim 1 , wherein combined weight of the one or more ascorbic compounds is from or about 20% to about 30% by weight compared to the total weight of the active ingredients.
4. The composition of claim 1 , wherein combined weight of the one or more flavonoid glycosides is from about 5% to about 20% by weight, or about 10% to about 15% by weight compared to the total weight of the active ingredients.
5. The composition of claim 1 , wherein the threonine is from about 0.1% to about 5% by weight, or about 0.5% to about 2% by weight compared to the total weight of the active ingredients.
6. The composition of claim 1 , wherein the taurine is from about 1% to about 10% by weight, or about 2% to about 6% by weight compared to the total weight of the active ingredients.
7. The composition of claim 1 , wherein the pyridoxine is from about 0.1% to about 2% by weight, or about 0.5% to about 1.5% by weight compared to the total weight of the active ingredients.
8. The composition of claim 1 , wherein the therapeutically effective amount of the lysine is in a single dose range of from about 1,000 mg to about 5,000 mg.
9. The composition of claim 1 , wherein the lysine is selected from the group consisting of L-lysine, L-lysine monohydrochloride, L-lysine di hydrochloride, L-lysine succinate, L-lysine glutamate, and L-lysine orotate.
10. The composition of claim 1 , wherein the one or more ascorbic compounds are selected from the group consisting of ascorbic acid, calcium ascorbate, magnesium ascorbate, potassium ascorbate, sodium ascorbate, manganese ascorbate, zinc ascorbate, iron ascorbate, copper ascorbate, boron ascorbate, molybdenum ascorbate, chromium ascorbate, ascorbyl palmitate, ascorbyl arachidonate, ascorbyl stearate, ascorbyl linoleate, ascorbyl linoleneate, and ascorbyl oleate.
11. The composition of claim 1 , wherein the one or more flavonoid glycosides are selected from the group consisting of hesperidin, rutin, naringin, and quercitrin.
12. The composition of claim 11 , wherein the one or more flavonoid glycosides include hesperidin and rutin.
13. The composition of claim 1 , wherein the pyridoxine is pyridoxine hydrochloride.
14. The composition of claim 1 , wherein the composition includes L-lysine monohydrochloride, ascorbic acid, hesperidin, rutin, threonine, taurine, and pyridoxine hydrochloride, and optionally an additional ascorbic compound.
15. The composition of claim 14 , wherein the additional ascorbic compound is selected from the group consisting of calcium ascorbate, niacinamide ascorbate, and ascorbyl palmitate.
16. The composition of claim 14 , wherein a single dose includes from about 2 g to about 3.5 g L-lysine, monohydrochloride; from about 0.1 g to about 1.5 g ascorbic acid; from about 0.2 g to about 0.8 g hesperidin; from about 0.1 g to about 0.5 g rutin; from about 0.04 g to about 0.08 g pyridoxine hydrochloride; from about 0.01 g to about 0.08 g threonine; and from about 0.02 g to about 0.4 g taurine.
17. The composition of claim 16 , wherein the additional ascorbic compound is selected from the group consisting of from about 0.5 g to about 0.75 g calcium ascorbate; from about 0.1 g to about 0.5 g niacinamide ascorbate; and from about 0.01 g to about 0.1 g ascorbyl palmitate.
18. The composition of claim 1 , wherein the composition is in a dosage form selected from the group consisting of powder, capsule, lozenge, troche, tablet, liquid, and caplet.
19. The composition of claim 18 , wherein the dosage form is a solid dosage form.
20. The composition of claim 18 , wherein the dosage form is a chewable form.
21. The composition of claim 18 , wherein the dosage form is an oral divided daily dosage form.
22. The composition of claim 1 , wherein the composition includes
from about 15% to about 35% by weight of one or more ascorbic compounds;
from about 40% to about 80% by weight of L-lysine hydrochloride;
from about 5% to about 20% by weight of combined flavonoid glycosides from about 1% to about 10% by weight of taurine;
from about 0.1% to about 5% by weight of L-threonine; and
from about 0.1% to about 2% by weight of pyridoxine hydrochloride; compared to total weight of active components.
23. The composition of claim 1 , wherein the composition does not include arginine.